Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. - Wikidata - wikimedia - TriplyDB

Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.

Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.

http://www.wikidata.org/entity/Q48183466

about

Widespread structural and functional connectivity changes in amyotrophic lateral sclerosis: insights from advanced neuroimaging research TARDBP mutation analysis in TDP-43 proteinopathies and deciphering the toxicity of mutant TDP-43 Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS Conjoint pathologic cascades mediated by ALS/FTLD-U linked RNA-binding proteins TDP-43 and FUS Accumulation of transactive response DNA binding protein 43 in mild cognitive impairment and Alzheimer disease The ubiquitin proteasome system in neuropathology A new subtype of frontotemporal lobar degeneration with FUS pathology Neuropathology of non-Alzheimer degenerative disorders Increased functional connectivity common to symptomatic amyotrophic lateral sclerosis and those at genetic risk Neuronal network disintegration: common pathways linking neurodegenerative diseases Redox Imbalance and Viral Infections in Neurodegenerative Diseases Dysregulated axonal RNA translation in amyotrophic lateral sclerosis Impaired Autophagy and Defective Mitochondrial Function: Converging Paths on the Road to Motor Neuron Degeneration Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis State of play in amyotrophic lateral sclerosis genetics The function of RNA-binding proteins at the synapse: implications for neurodegeneration Mitochondrial dysfunction in amyotrophic lateral sclerosis - a valid pharmacological target?Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic Trials FUS and TARDBP but not SOD1 interact in genetic models of amyotrophic lateral sclerosis TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets.Frontotemporal dementia: a bridge between dementia and neuromuscular disease The emerging role of peptidyl-prolyl isomerase chaperones in tau oligomerization, amyloid processing, and Alzheimer's disease Prion-like Mechanism in Amyotrophic Lateral Sclerosis: are Protein Aggregates the Key?Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6 The complex molecular biology of amyotrophic lateral sclerosis (ALS)Oxr1 improves pathogenic cellular features of ALS-associated FUS and TDP-43 mutations Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis TDP-43 identified from a genome wide RNAi screen for SOD1 regulators β-amyloid triggers ALS-associated TDP-43 pathology in AD models A randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosis Selective frontoinsular von Economo neuron and fork cell loss in early behavioral variant frontotemporal dementia.TARDBP 3'-UTR variant in autopsy-confirmed frontotemporal lobar degeneration with TDP-43 proteinopathy Parsing Disease-relevant Protein Modifications from Epiphenomena: Perspective on the Structural Basis of SOD1-Mediated ALS.The sour side of neurodegenerative disorders: the effects of protein glycation.Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis.A genetic model of amyotrophic lateral sclerosis in zebrafish displays phenotypic hallmarks of motoneuron disease Expansive gene transfer in the rat CNS rapidly produces amyotrophic lateral sclerosis relevant sequelae when TDP-43 is overexpressed.Selective forelimb impairment in rats expressing a pathological TDP-43 25 kDa C-terminal fragment to mimic amyotrophic lateral sclerosis.

P2860

Q21285058-CEF07F3B-9062-4730-BEFC-3D5B996585A9 Q24594172-D8D8EACF-DFC8-4269-9C33-4E8D08A600F2 Q24600027-14D337AE-1630-4753-A12D-07BA2DDD1E01 Q24630100-0236616C-1A64-4409-93E7-44558E08192D Q24633692-9BD7692F-3C1F-467C-8BED-EC4B42F0C34F Q24634807-4A446B5C-45DC-46BB-A856-C6E5C922FAEF Q24634907-54EF5FE7-EA05-45F1-9726-B37D5206B0D2 Q24644208-86CE82EA-E551-4FDF-B4E4-B8716C120FAE Q24647697-C7862B5B-1853-4507-A098-C0B7A344ED95 Q24657571-DDF5123E-7146-4F6F-BB1C-66D6052F0990 Q24658568-B9A55D5D-4D41-4651-B92B-1F726924E296 Q26750287-254223B6-B8CE-4BA5-8C41-862570D7CF2F Q26750630-97F121CE-48CE-4450-9F2F-72ADB5B76294 Q26753110-925045C0-0F9B-4270-BBB6-470EDDBB9DBE Q26766040-98746D43-8585-4098-9634-F99A62AF73BC Q26863439-351266AE-F5A2-4AC1-A5DE-F15E61968CF0 Q26864816-43175D0F-27ED-47FD-90E9-2544534FFE8A Q26991684-C46490C8-7E0F-4F04-924D-A27606784D14 Q27013585-D11D91B9-EBE8-4500-B1E2-3CDCECD5F0EA Q27021917-92D765C9-BB5D-4904-AE99-8A050C9C7BD4 Q27339258-538497B1-DAE1-450B-B50D-7A44BC196C0E Q28080628-EB50279C-5093-4A43-9A27-3CC881B40608 Q28081198-FDEE8E13-8D49-4EDD-8DB7-FDE4F81C3A74 Q28085108-B07A8FAF-9660-46FF-A6DA-AE6ACB1069A5 Q28087798-2547EE9A-D590-4157-B0E9-611C87B03FF0 Q28236805-8B22E69B-64CD-45AD-850C-EE4BE8021034 Q28263899-F8ADF6AE-0804-4784-9735-07107F57E14B Q28383058-D0B2C104-8CFA-4C15-B029-651AEA43AEC8 Q28473603-1BB00B82-020D-4093-A355-B8454189F809 Q28482611-2292B038-C270-446F-8094-0574C2357EA4 Q28580544-2329E510-9A1A-4115-8E80-FE37F9972083 Q28728672-EEDF339C-4C79-4656-B9D5-90E7169A3C40 Q28732862-DB1DFA27-DBC6-4597-B003-C0BA8CAA1881 Q28749802-3D64615A-8B5B-4B04-B635-5971EA243D87 Q30101060-A92BC4EC-3496-40C4-9645-2FD7A31B773D Q30386079-D264A84F-03A7-458E-8552-AC096FA573C7 Q30494776-7915A933-BA3D-4D34-BADB-01A88C35B7FC Q30496374-06C0891E-D415-476A-96F3-541144D1B074 Q30497589-B7EC03F9-D11A-4FEF-BC15-DD4E89C9C5CF Q30541190-A6576657-70C9-430A-B66B-838F395ECBFE

P2860

Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.

http://www.wikidata.org/entity/Q48183466

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Pathological TDP-43 distinguis ...... sclerosis with SOD1 mutations.

@en

Pathological TDP-43 distinguis ...... sclerosis with SOD1 mutations.

@nl

type

label

Pathological TDP-43 distinguis ...... sclerosis with SOD1 mutations.

@en

Pathological TDP-43 distinguis ...... sclerosis with SOD1 mutations.

@nl

prefLabel

Pathological TDP-43 distinguis ...... sclerosis with SOD1 mutations.

@en

Pathological TDP-43 distinguis ...... sclerosis with SOD1 mutations.

@nl

P1433

Q48183466-A825CBED-0047-4245-9CFA-038CBBBB5707

P1476

Q48183466-2C7D202A-4E47-4863-B5EA-D7CB956D8B9A

P2093

Q48183466-1014F6E1-8887-4531-BFEE-4E5E7BD4FBBE

Q48183466-2A184DFD-1590-493D-B373-97911907648C

Q48183466-2F20B36E-993C-42AE-8901-B35B2904BD2F

Q48183466-4F181058-80AA-4CDD-B9E9-465CB96CD626

Q48183466-5E870DB1-0809-4A6A-904F-CD62EC5D7EB7

Q48183466-68A76F1A-D334-4DA2-BF8A-E67EB8865E79

Q48183466-6C6320E9-528E-4A55-9578-FEE4306EA94F

Q48183466-700FBA55-0D59-46EF-ADB4-3A5FA3FAAF72

Q48183466-7A85A1FF-68B7-410F-97EA-0C8BBB04206D

Q48183466-8008D888-6166-4554-A548-658C438CCDC9

P304

Q48183466-3B8FCB15-E494-44D2-ABED-94BD6C773906

P31

Q48183466-FC5CB624-0411-4DDB-B752-1A8944F2F7F7

P356

Q48183466-8E027870-7C6B-4ADA-8F19-3D6D63D27ABF

P433

Q48183466-676D7547-D199-4008-BB46-7ABAE0A1D1EE

P478

Q48183466-ACD9B94B-13A7-4543-BD0D-F3F672331C2F

P50

Q48183466-3C20771D-7F0C-423B-B582-F751D724DAF8

Q48183466-4E073F2A-D5AC-48EC-958C-8DA11E3FFDC0

Q48183466-6A3AD088-68A0-4166-97E3-6E0CD4A647E9

Q48183466-76D2CD81-67EF-468F-883F-6381670CD0AD

Q48183466-82A91407-D7C8-4232-921F-004020207613

P577

Q48183466-F2BD3F7E-DA11-4814-9BFA-277F14645736

P5875

Q48183466-FC2DD277-B024-4FA0-B493-7D8193DAFE2A

P698

Q48183466-2B1A3499-048D-46E5-BA68-B991DE60BC01

P921

Q48183466-D834C696-B1EE-487A-A9C3-B70A77631B0C

P356

P1433

Annals of Neurology

P1476

Pathological TDP-43 distinguis ...... sclerosis with SOD1 mutations

@en

P2093

Andrew Eisen

http://www.w3.org/2001/XMLSchema#string

Camelia M Monoranu

http://www.w3.org/2001/XMLSchema#string

Eileen H Bigio

http://www.w3.org/2001/XMLSchema#string

Felix Geser

http://www.w3.org/2001/XMLSchema#string

Hans A Kretzschmar

http://www.w3.org/2001/XMLSchema#string

Heather Stewart

http://www.w3.org/2001/XMLSchema#string

Ian R A Mackenzie

http://www.w3.org/2001/XMLSchema#string

John Q Trojanowski

http://www.w3.org/2001/XMLSchema#string

John Ravits

http://www.w3.org/2001/XMLSchema#string

Leo McClusky

http://www.w3.org/2001/XMLSchema#string

P304

427-434

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.21147

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

61

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6361097

http://www.w3.org/2001/XMLSchema#string

P698

17469116

http://www.w3.org/2001/XMLSchema#string

P921

amyotrophic lateral sclerosis